Health Canada to propose interim solution to close cancer drugs oversight gap

TORONTO – There may be a temporary fix to eliminate a jurisdictional grey area believed to have contributed to more than 1,200 patients receiving diluted chemotherapy drugs.

Afficher le reportage au complet